Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?
Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...
GLP-1s and Brian Thompson's killing loom large at top health-care conference
This year’s JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in ...
Medicare to negotiate prices for weight loss drugs: What to know
The Biden administration says it will be including weight loss drugs like Ozempic and Wegovy in the next round of drug ...
Morningstar22h
Obesity Drug Market: The Next Wave of GLP-1 Competition
New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...
Columbus Dispatch14h
Sherrod Brown mulls 'post-Senate mission,' doesn't rule out future run for office in Ohio
Despite the loss, speculation about Brown's future has ... − but said his staff has been cooperative and hopes to see both new senators pick up their constituent services. Moreno will take ...